Evaluation of the Effect of the Physiotherapy on Mobility and Functional Disorders of the Musculoskeletal System in People With Multiple Sclerosis

CompletedNot a drug-phase studyMS (type not specified)NCT04973501

What it found

No results found

We found no results in the registry or in papers.

This trial finished 8 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • Manual physiotherapeutic correction (MFK) Method
  • Dynamic Neuromuscular Stabilization (DNS) Method

What it measured

Main measures

  • Timed Up and Go (TUG)

    six months

    Walking and mobility
  • Berg Balance Scale (BBS)

    six months

    Walking and mobility
  • Dynamic Gait Index (DGI)

    six months

    Walking and mobility
  • Five times Sit to Stand test (5STS)

    six months

  • 2-Minute Walk Test (2MWT)

    six months

    Walking and mobility
  • Symbol Digit Modalities Test (SDMT)

    six months

    Thinking and memory
  • Four Square Step Test (FSST)

    six months

Other measures (6)

  • Questionnaires - The Fatigue scale for motor and cognitive functions (FSMC)

    six months

    Thinking and memoryFatigue
  • Questionnaires -Multiple Sclerosis Impact Scale (MSIS-29)

    six months

    Quality of life (reported by participants)
  • Questionnaires - Euroqol-5 dimensions-5 levels health questionnaire

    six months

    Walking and mobilityPainMood and sleepQuality of life (reported by participants)
  • Questionnaires -Multiple Sclerosis Walking Scale-12 (MSWS-12)

    six months

    Walking and mobility
  • Questionnaires - Rivermead Mobility (RMI)

    six months

    Walking and mobility
  • Questionnaires- Activities-specific Balance Confidence Scale (ABC)

    six months

    Walking and mobility

Who could take part

MS (type not specified) · 18 to 70

Show the full criteria

Inclusion criteria

* exact diagnosis of MS stated by neurologist * Expanded Disability Status Scale (EDSS) ≥ 2 and ≤ 6,5 * no previous physiotherapy in six months * no clinical relapses and changes in pharmacotherapy in the previous month or during the rehabilitation trial * ability to undergo ambulatory physiotherapy

Exclusion criteria

* other neurological disease or conditions disabling movement (e.g. stroke, pregnancy, fracture)

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The randomized controlled trial is aimed to study the efficacy of treatment approaches based on developmental kinesiology models and its impact on balance, gait and mobility in people with mild to severe multiple sclerosis (pwMS). The main goal is to compare two out-patient physiotherapeutic methods, that will be attended 1-hour twice a week for one month and once a week for next two months (16 therapies in total). The efficacy will be assessed by a blinded independent clinical examiner using clinical examination and questionnaire survey one month before the therapy programme, immediately before and after the therapy and two months after termination of the therapy.

Loading reviews and guidelines…

History

    1. Started

      May 2016

    2. Main results due

      May 2018

    3. Finished

      Dec 2020

    Assembled by software from public sources.